Treating Advanced Metastatic Pancreatic Cancer: Current Challenges and Future Opportunities

Treating Advanced Metastatic Pancreatic Cancer: Current Challenges and Future Opportunities
Treating Advanced Metastatic Pancreatic Cancer: Current Challenges and Future Opportunities
CME, CPE
Vincent J. Picozzi, Jr., MD, MMM
Release Date: January 23, 2019
Expiration Date: January 23, 2020

Pancreatic cancer is the hardest to treat out of any major cancer, both biologically and clinically, which is why clinicians face so many unique challenges. However, there are efforts being taken to improve patient outcomes. In this activity, Dr. Vincent Picozzi from the Virginia Mason Medical Center will outline the current pipeline across advanced metastatic pancreatic cancer treatment. He will also summarize recent findings regarding risk factors, biology, and multimodality treatment.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation
Begin, Earn CreditView Only, No CreditGet Certificate